JP2022176154A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022176154A5 JP2022176154A5 JP2022078503A JP2022078503A JP2022176154A5 JP 2022176154 A5 JP2022176154 A5 JP 2022176154A5 JP 2022078503 A JP2022078503 A JP 2022078503A JP 2022078503 A JP2022078503 A JP 2022078503A JP 2022176154 A5 JP2022176154 A5 JP 2022176154A5
- Authority
- JP
- Japan
- Prior art keywords
- concentration
- pharmaceutical composition
- composition according
- polysorbate
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021080729 | 2021-05-12 | ||
| JP2021080729 | 2021-05-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022176154A JP2022176154A (ja) | 2022-11-25 |
| JP2022176154A5 true JP2022176154A5 (enExample) | 2025-05-19 |
Family
ID=84029664
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022078503A Pending JP2022176154A (ja) | 2021-05-12 | 2022-05-11 | ムコ多糖症ｉ型の治療用医薬組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240269244A1 (enExample) |
| EP (1) | EP4335459A4 (enExample) |
| JP (1) | JP2022176154A (enExample) |
| KR (1) | KR20240007163A (enExample) |
| CN (1) | CN117279665A (enExample) |
| TW (1) | TW202306992A (enExample) |
| WO (1) | WO2022239817A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116997352A (zh) * | 2021-03-24 | 2023-11-03 | Jcr制药股份有限公司 | 稳定的水性药物组合物或冷冻干燥药物组合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6149909A (en) | 1995-06-23 | 2000-11-21 | Women's And Children's Hospital | Synthetic α-L-iduronidase and genetic sequences encoding same |
| JP6279466B2 (ja) | 2012-04-27 | 2018-02-14 | Ｊｃｒファーマ株式会社 | 新規な発現ベクター |
| CA2990785C (en) * | 2015-06-24 | 2024-11-12 | Jcr Pharmaceuticals Co., Ltd. | ANTI-HUMAN TRANSFERRIN RECEPTOR ANTIBODIES CROSSING THE BLOOD-BRAIN BARRIER |
| TWI791006B (zh) * | 2016-12-26 | 2023-02-01 | 日商Ｊｃｒ製藥股份有限公司 | 包含bdnf之融合蛋白質 |
| TWI833178B (zh) * | 2016-12-26 | 2024-02-21 | 日商Ｊｃｒ製藥股份有限公司 | 通過血腦障壁之新穎抗人類運鐵蛋白受體抗體 |
| MX2019007824A (es) * | 2016-12-28 | 2019-09-09 | Japan Chem Res | Preparacion liofilizada. |
| WO2019049967A1 (ja) * | 2017-09-07 | 2019-03-14 | Ｊｃｒファーマ株式会社 | 水性医薬組成物 |
| BR112023018268A2 (pt) * | 2021-03-09 | 2023-10-31 | Japan Chem Res | Método para produzir uma proteína de fusão |
| CN116997352A (zh) * | 2021-03-24 | 2023-11-03 | Jcr制药股份有限公司 | 稳定的水性药物组合物或冷冻干燥药物组合物 |
-
2022
- 2022-05-11 EP EP22807516.4A patent/EP4335459A4/en active Pending
- 2022-05-11 WO PCT/JP2022/020001 patent/WO2022239817A1/ja not_active Ceased
- 2022-05-11 KR KR1020237038968A patent/KR20240007163A/ko not_active Withdrawn
- 2022-05-11 CN CN202280033472.XA patent/CN117279665A/zh active Pending
- 2022-05-11 JP JP2022078503A patent/JP2022176154A/ja active Pending
- 2022-05-11 US US18/290,001 patent/US20240269244A1/en active Pending
- 2022-05-12 TW TW111117776A patent/TW202306992A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7856872B2 (ja) | 組織石灰化の治療方法 | |
| TW520291B (en) | Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies | |
| US10093728B2 (en) | Pharmaceutical formulations of TNF-alpha antibodies | |
| JP2002544174A5 (enExample) | ||
| GB2112641A (en) | The use of peptides as medicaments | |
| JP2023527563A5 (enExample) | ||
| EP0939648B1 (en) | Rotavirus vaccine formulations | |
| CA2378864A1 (en) | Rotavirus vaccine formulations | |
| AU2014249534A1 (en) | Use of levocetirizine and montelukast in the treatment of vasculitis | |
| TWI897893B (zh) | 含有血清白蛋白與生長激素之融合蛋白質之水性醫藥組成物 | |
| KR20250048156A (ko) | 제제에 접합된 인슐린 유사 성장 인자 1 수용체 리간드를 사용한 자가면역 질환의 치료 | |
| TW202306992A (zh) | 第i型黏多醣症之治療用醫藥組成物 | |
| JP2025527521A (ja) | 急性呼吸不全の治療 | |
| Roberton et al. | Failure of intraventricular gammaglobulin and alpha interferon for persistent encephalitis in congenital hypogammaglobulinaemia. | |
| Stratigos et al. | Treatment of gonorrhoea with spectinomycin hydrochloride | |
| CN120936377A (zh) | 一种稳定的抗vegf抗体制剂 | |
| WO2026026827A1 (zh) | 抗il-5抗体制剂及其制备方法 | |
| JP6578546B2 (ja) | Ｌｔ阻害４価ペプチドおよびｅｔｅｃ感染症治療薬 | |
| CN121194795A (zh) | 膜联蛋白a5蛋白质与抗vegf药剂作为组合疗法用于治疗黄斑水肿或视网膜静脉阻塞 | |
| AU2008202660B2 (en) | Rotavirus vaccine formulations | |
| WO2013022058A1 (ja) | ビリルビン排泄促進剤 | |
| JP2688733B2 (ja) | 消化管粘膜障害の予防及び治療剤 | |
| CN119907677A (zh) | 在治疗黄斑水肿或视网膜静脉阻塞中使用的单体膜联蛋白a5 | |
| CN119139449A (zh) | 一种多肽在调节血糖中的应用 | |
| Deballi et al. | Changes in renal function after liver transplantation under FK 506 |